We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYBT
2751
Zhengye Biotechnology Holding
ZYBT
$55.9M
| $68.2K | ﹤0.01% |
59,286
+24,697
| +71% | +$54.7K |
|
2752
Q32 Bio
QTTB
$448M
| $67.6K | ﹤0.01% |
+20,353
| New | +$57.5K |
|
|
YHC
2753
LQR House Inc
YHC
$1.88M
| $67.3K | ﹤0.01% |
+748
| New | +$65.3K |
|
2754
AYTU BioPharma
AYTU
$22.5M
| $67.2K | ﹤0.01% |
+25,860
| New | +$58K |
|
|
ZONE
2755
CleanCore Solutions
ZONE
$97.6M
| $67.1K | ﹤0.01% |
258,204
+242,980
| +1,596% | +$203K |
|
|
YDDL
2756
One and One Green Technologies
YDDL
$100M
| $66.9K | ﹤0.01% |
+12,895
| New | +$64.2K |
|
2757
Noodles & Co
NDLS
$90.6M
| $66.9K | ﹤0.01% |
11,843
+8,238
| +229% | +$46.8K |
|
2758
Rallybio
RLYB
$84.8M
| $66.8K | ﹤0.01% |
12,164
+4,775
| +65% | +$24.6K |
|
|
FMST
2759
Foremost Lithium Resource & Technology
FMST
$23.1M
| $66.4K | ﹤0.01% |
+31,324
| New | +$92.6K |
|
2760
Creative Realities
CREX
$41.3M
| $66.1K | ﹤0.01% |
+25,326
| New | +$70.3K |
|
2761
CEL-SCI Corp
CVM
$20.3M
| $65.8K | ﹤0.01% |
+12,507
| New | +$91.8K |
|
2762
Nautilus Biotechnolgy
NAUT
$141M
| $65.5K | ﹤0.01% |
33,608
-12,116
| -26% | -$19.9K |
|
|
QTEX
2763
QTREX Quantum
QTEX
$47.6M
| $65.3K | ﹤0.01% |
72,533
+4,075
| +6% | +$4.27K |
|
2764
Valens Semiconductor
VLN
$161M
| $64.9K | ﹤0.01% |
+45,692
| New | +$75.3K |
|
2765
NeuroOne Medical Technologies
NMTC
$15M
| $64.8K | ﹤0.01% |
14,242
+10,860
| +321% | +$49.5K |
|
2766
Research Solutions
RSSS
$74.6M
| $64.8K | ﹤0.01% |
+22,030
| New | +$68.7K |
|
2767
Magnachip Semiconductor
MX
$112M
| $64.7K | ﹤0.01% |
+25,383
| New | +$70.7K |
|
|
PPSI
2768
Pioneer Power Solutions
PPSI
$30.7M
| $64.6K | ﹤0.01% |
+13,653
| New | +$57.2K |
|
2769
Metalpha Technology Holding
MATH
$43.8M
| $64.4K | ﹤0.01% |
30,678
-3,941
| -11% | -$11.5K |
|
2770
Fathom Holdings
FTHM
$26.5M
| $64.4K | ﹤0.01% |
63,748
+13,911
| +28% | +$18.7K |
|
2771
GameSquare
GAME
$37.2M
| $64.2K | ﹤0.01% |
166,692
+53,489
| +47% | +$30.9K |
|
|
EEX
2772
DELISTED
Emerald Holding
EEX
| $64.2K | ﹤0.01% |
14,356
+1,741
| +14% | +$7.49K |
|
2773
Flux Power
FLUX
$11.4M
| $63.8K | ﹤0.01% |
+50,243
| New | +$148K |
|
2774
KLX Energy Services
KLXE
$43.3M
| $63.8K | ﹤0.01% |
33,756
-7,783
| -19% | -$13.6K |
|
2775
ZKH Group
ZKH
$470M
| $63.3K | ﹤0.01% |
+17,211
| New | +$53.5K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.